---
figid: PMC9127157__fendo-13-863541-g004
figtitle: Emerging Roles and Therapeutic Implications of Epigenetic Modifications
  in Ovarian Cancer
organisms:
- Homo sapiens
- Mus musculus
- prion
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC9127157
filename: fendo-13-863541-g004.jpg
figlink: /pmc/articles/PMC9127157/figure/f4/
number: F4
caption: Epigenetic modifications in the tumor microenvironment. NNMT can diminish
  histone methylation in CAFs, and CAFs secrete miR-21 and CXCL14, which enhance OC
  development, metastasis, and therapy resistance. MiR-21, miR-92a, and miR-221, which
  are abundant in MSC-derived exosomes, are associated with OC development. Epigenetic
  alterations in histone H3 lysine4 and histone H3 lysine27 methylation in TAMs can
  induce macrophage M2 polarization. Epithelial ovarian cancer (EOC)-released exosomal
  miRNAs and lncRNAs via the SOCS3/STAT3 pathway and miR-146b-5P/TRAF6/NF-κB/MMP2
  pathway regulate the progression, migration and drug resistance of OC. CAF, cancer-associated
  fibroblast; MSC, mesenchymal stem cell; TAM, tumor-associated macrophage; CSC, cancer
  stem cell; NNMT, nicotinamide N-methyltransferase; DNMT, DNA methyltransferase;
  APAF1, apoptosis protease activator-1; APAF6, TNF receptor associated factor 6.
papertitle: The Emerging Roles and Therapeutic Implications of Epigenetic Modifications
  in Ovarian Cancer.
reftext: Yu Wang, et al. Front Endocrinol (Lausanne). 2022;13:863541.
year: '2022'
doi: 10.3389/fendo.2022.863541
journal_title: Frontiers in Endocrinology
journal_nlm_ta: Front Endocrinol (Lausanne)
publisher_name: Frontiers Media S.A.
keywords: ovarian cancer | drug resistance | cancer epigenetics | DNA methylation
  | histone modifications | non-coding RNA | epigenetic therapy
automl_pathway: 0.9600694
figid_alias: PMC9127157__F4
figtype: Figure
redirect_from: /figures/PMC9127157__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9127157__fendo-13-863541-g004.html
  '@type': Dataset
  description: Epigenetic modifications in the tumor microenvironment. NNMT can diminish
    histone methylation in CAFs, and CAFs secrete miR-21 and CXCL14, which enhance
    OC development, metastasis, and therapy resistance. MiR-21, miR-92a, and miR-221,
    which are abundant in MSC-derived exosomes, are associated with OC development.
    Epigenetic alterations in histone H3 lysine4 and histone H3 lysine27 methylation
    in TAMs can induce macrophage M2 polarization. Epithelial ovarian cancer (EOC)-released
    exosomal miRNAs and lncRNAs via the SOCS3/STAT3 pathway and miR-146b-5P/TRAF6/NF-κB/MMP2
    pathway regulate the progression, migration and drug resistance of OC. CAF, cancer-associated
    fibroblast; MSC, mesenchymal stem cell; TAM, tumor-associated macrophage; CSC,
    cancer stem cell; NNMT, nicotinamide N-methyltransferase; DNMT, DNA methyltransferase;
    APAF1, apoptosis protease activator-1; APAF6, TNF receptor associated factor 6.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - APAF1
  - LINC00092
  - NNMT
  - DNMT1
  - DNMT3A
  - DNMT3B
  - DNMT3L
  - MIR21
  - CXCL14
  - KAT2B
  - STAT3
  - SOCS3
  - TRAF6
  - NFKB1
  - MSC
  - SLC25A37
  - TAM
  - STIM1
  - MIR221
  - Apaf1
  - Nnmt
  - Dnmt1
  - Mir21a
  - Cxcl14
  - Caf
  - Stat3
  - Socs3
  - Traf6
  - Nfkb1
  - Msc
  - Mir221
  - apaf1
  - cxcl14
  - stat3
  - socs3a
  - traf6
  - msc
  - dre-mir-221
---
